Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FLCN-mutated eosinophilic renal tumors: clinicopathologic and molecular analysis of five cases highlighting morphologic heterogeneity. | Virchows Arch | 2026 | 41162600 | PubTator, text mining | PubMed |
| Chromosomal alterations in 7, 17, and Y demonstrate comparable sensitivity and superior specificity to diffuse strong AMACR immunostaining for papillary renal cell carcinoma. | Ann Diagn Pathol | 2026 | 41151238 | PubTator, text mining | PubMed |
| Clinicopathologic and radio-genomic insights into hepatic epithelioid hemangioma: An illustrated review. | Hum Pathol | 2026 | 41101391 | PubTator, text mining | PubMed |
| TFE3-Rearranged PEComa(-Like Neoplasm) of the Chest Wall Diagnosed by Fine-Needle Aspiration: A Case Report. | Diagn Cytopathol | 2026 | 41045153 | PubTator, text mining | PubMed |
| YAP1::TFE3 mediates endothelial-to-mesenchymal plasticity in epithelioid hemangioendothelioma. | Mol Oncol | 2026 | 40819258 | PubTator, text mining | PubMed |
| Diagnostic Pitfalls of TFE3-Rearranged Perivascular Epithelioid Cell Tumor of the Kidney. | Int J Surg Pathol | 2026 | 40791094 | PubTator, text mining | PubMed |
| Primary cutaneous epithelioid hemangioendothelioma of the temporal region: a case report. | Pan Afr Med J | 2025 | 41858970 | PubTator, text mining | PubMed |
| Pancreatic PEComa: Case Report of an Extremely Rare Tumor. | Arch Iran Med | 2025 | 41852007 | PubTator, text mining | PubMed |
| Surgical management of giant Xp11.2 translocation renal cell carcinoma with multivisceral invasion: a case report of en bloc resection and targeted-immunotherapy success. | Front Oncol | 2025 | 41613556 | PubTator, text mining | PubMed |
| Primary Intracranial Alveolar Soft Part Sarcoma: Systematic Review. | Pak J Med Sci | 2025 | 41522395 | PubTator, text mining | PubMed |
| Modulation of viral replication, autophagy and apoptosis by induction and mutual regulation of transcription factors EB and E3 during coronavirus infection. | Front Microbiol | 2025 | 41450945 | PubTator, text mining | PubMed |
| Recent progress in the clinicopathological characteristics of alveolar soft part sarcoma. | Front Med (Lausanne) | 2025 | 41446840 | PubTator, text mining | PubMed |
| TFE3-rearranged renal cell car cinoma with massive calcification: Imaging-pathologic correlation. | J Clin Imaging Sci | 2025 | 41409393 | PubTator, text mining | PubMed |
| Perivascular Epithelioid Cell Neoplasm of the Uterus: A Case Report. | J Obstet Gynaecol Res | 2025 | 41386702 | PubTator, text mining | PubMed |
| Stimulator of interferon genes immunohistochemical expression in the spectrum of extrarenal perivascular epithelioid cell lesions. | Sci Rep | 2025 | 41381713 | PubTator, text mining | PubMed |
| Mechanistic study of TFE3 breakage in TFE3-rearranged renal cell carcinoma: the perspective of non-canonical DNA structures and their stability. | Front Genet | 2025 | 41367616 | PubTator, text mining | PubMed |
| [Ossifying fibromyxoid tumor with rare fusion subtypes: a clinicopathological analysis]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 41355112 | PubTator, text mining | PubMed |
| Alveolar Soft Part Sarcoma in a 44-year-Old Female: A Case from Uganda. | Int Med Case Rep J | 2025 | 41334239 | PubTator, text mining | PubMed |
| A Rare Uterine Malignancy: A Case of High-Grade PEComa Defying Routine Immunohistochemistry. | Turk Patoloji Derg | 2025 | 41328914 | PubTator, text mining | PubMed |
| Application of three-dimensional Superb micro-vascular imaging (3D-SMI) combined with quantitative blood flow analysis in the noninvasive diagnosis of renal tumors. | Ultrasound J | 2025 | 41324744 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=8